Long-Term Administration of High-Fat Diet Corrects Abnormal Bone Remodeling in the Tibiae of Interleukin-6-Deficient Mice |
| |
Authors: | Wei Feng Bo Liu Di Liu Tomoka Hasegawa Wei Wang Xiuchun Han Jian Cui Yimin Kimimitsu Oda Norio Amizuka Minqi Li |
| |
Affiliation: | Department of Bone Metabolism, School of Stomatology Shandong University, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, China (WF, BL, DL, WW, XH, JC, ML);Department of Developmental Biology of Hard Tissue, Graduate School of Dental Medicine(TH, NA) and Department of Advanced Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan (Y);Division of Biochemistry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan (KO) |
| |
Abstract: | In this study, we aimed to evaluate the influence of diet-induced obesity on IL-6 deficiency-induced bone remodeling abnormality. Seven-week-old IL-6-/- mice and their wild type (WT) littermates were fed a standard diet (SD) or high-fat diet (HFD) for 25 weeks. Lipid formation and bone metabolism in mice tibiae were investigated by histochemical analysis. Both IL-6-/- and WT mice fed the HFD showed notable body weight gain, thickened cortical bones, and adipose accumulation in the bone marrow. Notably, the HFD normalized the bone phenotype of IL-6-/- mice to that of their WT counterpart, as characterized by a decrease in bone mass and the presence of an obliquely arranged, plate-like morphology in the trabecular bone. Alkaline phosphatase and osteocalcin expressions were attenuated in both genotypes after HFD feeding, especially for the IL-6-/- mice. Meanwhile, tartrate-resistant acid phosphatase staining was inhibited, osteoclast apoptosis rate down-regulated (revealed by TUNEL assay), and the proportion of cathepsin K (CK)-positive osteoclasts significantly increased in IL-6-/- mice on a HFD as compared with IL-6-/- mice on standard chow. Our results demonstrate that HFD-induced obesity reverses IL-6 deficiency-associated bone metabolic disorders by suppressing osteoblast activity, upregulating osteoclastic activity, and inhibiting osteoclast apoptosis. |
| |
Keywords: | IL-6 obesity bone metabolism osteoblast osteoclast |
|
|